SCHEMBL5377995

SCHEMBL5377995

O=S(=O)(Nc1ccc2ncccc2c1)c1cc(Cl)ccc1Cl

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALPL P05186 4/20 0.72
ALDH1A1 P00352 4/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
CYP3A4 P08684 1/20 0.59
PPARG P37231 1/20 0.59
LMNA P02545 1/20 0.57
HTT P42858 2/20 0.57
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
MAPT P10636 1/20 0.54
HSD11B1 P28845 1/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
HSP90AA1 P07900 2/20 0.52
HSP90AB1 P08238 2/20 0.52
MAPK1 P28482 1/20 0.51
FBP1 P09467 1/20 0.51
SGK1 O00141 1/20 0.51
AR P10275 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981076 0.83 ALDH1A1 (0.76) ALPLALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL6980375 0.81 LMNA (0.65) ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL2055421 0.81 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2CYP3A4PPARGLMNA
SCHEMBL5342156 0.81 SLC40A1 (0.62) ALPLALDH1A1SMN1; SMN2CYP3A4PPARG
SCHEMBL5348053 0.80 ALPL (0.58) ALPLALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL6984890 0.77 ALDH1A1 (0.67) ALPLALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL6981195 0.77 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2LMNAHTTMAPT
SCHEMBL6985862 0.76 ALDH1A1 (0.78) ALPLALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL359841 0.76 NR4A2 (0.70) ALDH1A1SMN1; SMN2HTTNPC1RAB9A
SCHEMBL6314173 0.75 ALDH1A1 (0.54) ALPLALDH1A1SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 ALPL 1926/4885ALDH1A1 378/4885SMN1; SMN2 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.